TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26762524

Group type: EXPERIMENTAL
Intervention: Lower blood pressure target (<130 mm Hg)
Number of subjects: 2610

Group type: COMPARATOR
Intervention: Higher blood pressure target (130‐149 mm Hg)
Number of subjects: 2610
Study: 23539079

Group type: EXPERIMENTAL
Intervention: Heavy-load weighted sled towing (n = 10)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Light-load weighted sled towing (n = 11)
Number of subjects: 21
Study: 23364781

Group type: EXPERIMENTAL
Intervention: Caudal block with 1 mL kg(‐1) 0.25% levobupivacaine
Number of subjects: 60
Study: 19713199

Group type: EXPERIMENTAL
Intervention: 20G vitrectomy
Number of subjects: 40

Group type: COMPARATOR
Intervention: 25G vitrectomy
Number of subjects: 40
Study: 17206693

Group type: EXPERIMENTAL
Intervention: Supported group (SG) receiving social support for 18 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (CG) receiving no social support
Number of subjects: 0
Study: 14966922

Group type: EXPERIMENTAL
Intervention: Erythropoietin (20,000 IU Epoetin alfa subcutaneously on days 0, 4, and 6) plus iron (100 mg im on days 1-6)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Iron only
Number of subjects: 27
Study: 11347747

Group type: EXPERIMENTAL
Intervention: L-arginine (3 g three times per day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (orally three times per day)
Number of subjects: 12
Study: 9396564

Group type: EXPERIMENTAL
Intervention: Formula containing 0.32-1.1% AA and 0.24-0.76% DHA
Number of subjects: 0

Group type: COMPARATOR
Intervention: Commercial formula devoid of AA and DHA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Breast milk with fortifier when indicated
Number of subjects: 0
Study: 7951238

Group type: EXPERIMENTAL
Intervention: CYP2D6(T) allele
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: D6(B)/D6(T) genotype
Number of subjects: 236

Group type: COMPARATOR
Intervention: Caucasian controls
Number of subjects: 236
Study: 2889679

Group type: EXPERIMENTAL
Intervention: 40 mg cinolazepam
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 30671869

Group type: EXPERIMENTAL
Intervention: Brexpiprazole 2–4 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brexpiprazole 1–4 mg/day (maintenance treatment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brexpiprazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28494892

Group type: COMPARATOR
Intervention: IV-PCA
Number of subjects: 108

Group type: COMPARATOR
Intervention: Ultrasound-guided single-shot TAP block with 0.2% ropivacaine (20mL) and IV-PCA
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Continuous TAP block using ultrasound-guidance with 0.2% ropivacaine at a basal rate of 3mL/h, bolus dose of 4mL, and a lockout interval of 30min for 48h postoperatively
Number of subjects: 108
Study: 24458265

Group type: EXPERIMENTAL
Intervention: Cold water immersion therapy
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (no cold water immersion therapy)
Number of subjects: 21
Study: 24684176

Group type: EXPERIMENTAL
Intervention: Planned feedback provided for 107 pedicle tracks, with 15 triggering an intraoperative alarm (evoked electromyogram response in leg muscles to stimulus intensity ≤ 10 mA).
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Break the blind feedback provided 29 times when testing revealed a particularly low threshold (≤ 4 mA) for evoked responses in leg muscles.
Number of subjects: 71

Group type: COMPARATOR
Intervention: No feedback category for 29 screws that were found to be at least 2 mm medial to the pedicle wall.
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Overall implementation of the neuromonitoring strategy during screw placement.
Number of subjects: 71
Study: 22424458

Group type: EXPERIMENTAL
Intervention: Drinking deep seawater (DSW)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Reverse osmotic (RO) water
Number of subjects: 42

Group type: COMPARATOR
Intervention: Magnesium-chloride fortified (MCF) water
Number of subjects: 42
Study: 19384122

Group type: EXPERIMENTAL
Intervention: Neuraxial (early) analgesia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Systemic (late) analgesia
Number of subjects: 0
Study: 16972117

Group type: EXPERIMENTAL
Intervention: Methylphenidate combined with 10 weeks of multimodal behavior therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Methylphenidate
Number of subjects: 50
Study: 16202350

Group type: EXPERIMENTAL
Intervention: Opportunistic screening
Number of subjects: 10000

Group type: EXPERIMENTAL
Intervention: Systematic screening
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Control group (routine practice)
Number of subjects: 10000
Study: 12660880

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Type 2 diabetes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Type 1 diabetes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thiazolidinedione treatment
Number of subjects: 0
Study: 10080464

Group type: EXPERIMENTAL
Intervention: Periprocedural myocardial infarction (MI)
Number of subjects: 2099

Group type: COMPARATOR
Intervention: No CK elevation
Number of subjects: 2099

Group type: COMPARATOR
Intervention: CK elevation to >3 times normal
Number of subjects: 2099

Group type: COMPARATOR
Intervention: CK elevation to >10 times normal
Number of subjects: 2099
Study: 7484023

Group type: EXPERIMENTAL
Intervention: 3% desflurane
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 6% desflurane
Number of subjects: 75

Group type: COMPARATOR
Intervention: 0.6% enflurane
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 50% N2O and O2
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: butorphanol tartrate
Number of subjects: 75
Study: 2149281

Group type: EXPERIMENTAL
Intervention: Toremifene (oral doses of 10-480 mg per day for one or five days)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Toremifene
Number of subjects: 27
Study: 7369562

Group type: EXPERIMENTAL
Intervention: Peritoneal dialysis catheter
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intracatheter
Number of subjects: 100
Study: 30058726

Group type: EXPERIMENTAL
Intervention: Twice daily oral 100 mg KH176 for 28 days
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 18
Study: 28134225

Group type: EXPERIMENTAL
Intervention: LABA (long-acting beta-agonist) such as indacaterol, vilanterol, or olodaterol used once a day.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LAMA (long-acting muscarinic antagonist) such as tiotropium, glycopyrronium, aclidinium, or umeclidinium.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined preparations of LAMA-LABA.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MABA (muscarinic antagonist and β2 agonist).
Number of subjects: 0
Study: 26489713

Group type: EXPERIMENTAL
Intervention: Transvaginal extraction
Number of subjects: 27

Group type: COMPARATOR
Intervention: Conventional extraction
Number of subjects: 27
Study: 23636925

Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE)
Number of subjects: 163
Study: 20939799

Group type: EXPERIMENTAL
Intervention: Fluocinolone acetonide intravitreal implant (Retisert)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluocinolone acetonide intravitreal implant (Iluvien)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination photocoagulation and pharmacotherapy
Number of subjects: 0
Study: 19640669

Group type: EXPERIMENTAL
Intervention: Propranolol and 4-hydroxy propranolol assay using solid phase extraction and liquid chromatography/electrospray tandem mass spectrometry
Number of subjects: 0
Study: 17595894

Group type: EXPERIMENTAL
Intervention: Digox 0.25 mg tablet from Pharlab Ind. Ltd., Brazil
Number of subjects: 30

Group type: COMPARATOR
Intervention: Digoxin 0.25 mg tablet from Laboratório Glaxo SmithKline, Brazil
Number of subjects: 30
Study: 15533493

Group type: EXPERIMENTAL
Intervention: Vardenafil 10 mg
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Vardenafil 20 mg
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 14740593

Group type: EXPERIMENTAL
Intervention: Controlled hyperventilation (hypocapnia)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normocapnic group
Number of subjects: 0
Study: 9850831

Group type: EXPERIMENTAL
Intervention: Social phobia diagnosis
Number of subjects: 1035

Group type: EXPERIMENTAL
Intervention: Social fears
Number of subjects: 1035

Group type: EXPERIMENTAL
Intervention: Co-occurring disorders
Number of subjects: 1035

Group type: EXPERIMENTAL
Intervention: Psychosocial impairment
Number of subjects: 1035

Group type: EXPERIMENTAL
Intervention: Professional help
Number of subjects: 1035
Study: 7851519

Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS) applied 80 ms before or 60 ms after the go-signal overlying the supplementary motor area (SMA)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Different stimulation intervals (160 ms and 120 ms before the go-signal; 100 ms, 140 ms or 240 ms after the go-signal) and inappropriate coil positioning (over the occipital cortex)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Low stimulator output
Number of subjects: 8
Study: 2528440

Group type: EXPERIMENTAL
Intervention: Etodolac (600 mg/day)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study: 363232

Group type: EXPERIMENTAL
Intervention: Cimetidine 1 g daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Carbenoxolone (for patients under 60)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Caved-(S) (for patients over 60)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Follow-up of healed ulcers
Number of subjects: 60
Study: 31730814

Group type: EXPERIMENTAL
Intervention: Anti-viral therapy
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Decrease in HBsAg
Number of subjects: 335

Group type: COMPARATOR
Intervention: HBcrAg conversion rates
Number of subjects: 335
Study: 28517974

Group type: EXPERIMENTAL
Intervention: DHA + aspirin therapy (2 g DHA + 81 mg aspirin daily)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo (placebo capsules)
Number of subjects: 55
Study: 25867448

Group type: EXPERIMENTAL
Intervention: Self-system therapy (SST)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Both treatments (CBT and SST)
Number of subjects: 49
Study: 22663759

Group type: EXPERIMENTAL
Intervention: Telephone consultation for 3 months
Number of subjects: 80

Group type: COMPARATOR
Intervention: Attendance education during monthly visits at the center
Number of subjects: 80
Study: 20523042

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stent (Xience v/Promus)
Number of subjects: 2678

Group type: COMPARATOR
Intervention: Sirolimus-eluting stent (Cypher Select+)
Number of subjects: 2678
Study: 18451229

Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 106

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 106
Study: 15347632

Group type: EXPERIMENTAL
Intervention: Endurance-trained men
Number of subjects: 14

Group type: COMPARATOR
Intervention: Untrained men
Number of subjects: 14
Study: 12686509

Group type: EXPERIMENTAL
Intervention: Duodenal acid infusion (0.1 N HCl)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Water infusion (control)
Number of subjects: 10
Study: 10553182

Group type: EXPERIMENTAL
Intervention: Music
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: White noise
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control
Number of subjects: 156
Study: 8678498

Group type: EXPERIMENTAL
Intervention: 5-FU (500-750 mg/body) and LV (30 mg/body) for 5 days
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 5-FU (500-750 mg/body) and LV (30 mg/body) plus cisplatin (10 mg/body)
Number of subjects: 21

Group type: COMPARATOR
Intervention: 5-FU/LV
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 5-FU/LV/CDDP
Number of subjects: 21
Study: 1872778

Group type: EXPERIMENTAL
Intervention: Mefenamic acid
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Naproxen
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Low dose monophasic combined oral contraceptive
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Low dose danazol
Number of subjects: 45
Study: 6681365

Group type: EXPERIMENTAL
Intervention: Cinnarizine
Number of subjects: 112

Group type: COMPARATOR
Intervention: Aviomarin and placebo
Number of subjects: 112
Study: 29117757

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone
Number of subjects: 372

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 372
Study: 30092948

Group type: EXPERIMENTAL
Intervention: ADMA tertile groups
Number of subjects: 5004

Group type: EXPERIMENTAL
Intervention: SDMA tertile groups
Number of subjects: 5004

Group type: EXPERIMENTAL
Intervention: ADMA and SDMA incorporation into CHA2DS2-VASc or HAS-BLED predictive models
Number of subjects: 5004
Study: 26879246

Group type: EXPERIMENTAL
Intervention: Strip shaving
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Regional shaving
Number of subjects: 200

Group type: COMPARATOR
Intervention: Both groups (strip shaving and regional shaving)
Number of subjects: 200
Study: 25140396

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg/day (R10)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 40 mg/day (R40)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 22189289

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin administration
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 42
Study: 19948517

Group type: EXPERIMENTAL
Intervention: Tonsillectomy
Number of subjects: 1015

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 1015
Study: 17661764

Group type: EXPERIMENTAL
Intervention: Octreotide (Sandostatin LAR 20 mg i.m.)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 17974149

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (CYP)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Cyclosporine (CsA)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Azathioprine (AZA)
Number of subjects: 22
Study: 15679243

Group type: EXPERIMENTAL
Intervention: Exclusive radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Concomitant cisplatin-based chemotherapy with radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (cisplatin-5FU) followed by local treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Partial surgery or radiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 10737578

Group type: EXPERIMENTAL
Intervention: Botulinum toxin injection in the internal anal sphincter on each side of the posterior midline (group I)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Botulinum toxin injection in the internal anal sphincter on each side of the anterior midline (group II)
Number of subjects: 50
Study: 8725483

Group type: EXPERIMENTAL
Intervention: Transurethral resection of the prostate (surgery)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Medical treatment (medication)
Number of subjects: 53
Study: 1328978

Group type: EXPERIMENTAL
Intervention: Estrogen-progestin hormone replacement therapy
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84

Group type: COMPARATOR
Intervention: Women who had never taken hormone replacement therapy
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Women who had ever taken hormone replacement therapy
Number of subjects: 84
Study: 3894171

Group type: EXPERIMENTAL
Intervention: prednisolone metasulphobenzoate enema
Number of subjects: 40

Group type: COMPARATOR
Intervention: prednisolone‐21‐phosphate enema
Number of subjects: 40
Study: 31564529

Group type: EXPERIMENTAL
Intervention: Co-testing
Number of subjects: 182119

Group type: EXPERIMENTAL
Intervention: HR-HPV screening
Number of subjects: 182119

Group type: COMPARATOR
Intervention: Cytology screening
Number of subjects: 182119
Study: 30640505

Group type: EXPERIMENTAL
Intervention: Brief motivational interview (BMI)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Attention-matched control (relaxation training [REL])
Number of subjects: 167
Study: 28606669

Group type: EXPERIMENTAL
Intervention: Rotary Mtwo instruments (VDW, Munich, Germany) with 8 files
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Reciproc system (VDW) with a single file
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Genius hybrid instruments with 3 files (1 rotary and 2 reciprocating files)
Number of subjects: 30
Study: 26376093

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (15-20 hours of training/week + restrictive diet)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Intensive resistance, intensive endurance, moderate mixed exercise modalities
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (healthy controls)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Intensive exercise program
Number of subjects: 90
Study: 23650408

Group type: EXPERIMENTAL
Intervention: Bendamustine plus rituximab (BR)
Number of subjects: 63
Study: 21159397

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Prone position
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Patient-comfort-scores
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Treatment times
Number of subjects: 25
Study: 19635587

Group type: COMPARATOR
Intervention: Basic office evaluation (BOE) prior to SUI surgery (No UDS arm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Basic office evaluation and urodynamic studies (UDS) prior to SUI surgery (UDS arm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preoperative UDS
Number of subjects: 0

Group type: COMPARATOR
Intervention: No UDS
Number of subjects: 0
Study: 17533068

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention including instructional materials, cues and aids, a video, brief counseling session, follow-up phone call, and tailored feedback letters.
Number of subjects: 1356

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention
Number of subjects: 1356

Group type: COMPARATOR
Intervention: Control intervention focused on diet
Number of subjects: 1356
Study: 15730803

Group type: EXPERIMENTAL
Intervention: Standardized Three Stages' Rehabilitation
Number of subjects: 52

Group type: COMPARATOR
Intervention: Normal internal medicine treatments (Control)
Number of subjects: 52
Study: 11174229

Group type: EXPERIMENTAL
Intervention: Report group (PRIME-MD results given to physician)
Number of subjects: 218

Group type: COMPARATOR
Intervention: No-report group (PRIME-MD results not given to physician)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Report group
Number of subjects: 218

Group type: COMPARATOR
Intervention: No-report group
Number of subjects: 218
Study: 9576535

Group type: EXPERIMENTAL
Intervention: Computer-based retraining of attentional impairments, 12 sessions for each of the two most impaired attention functions.
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Computer-based retraining of attentional impairments
Number of subjects: 22
Study: 7931752

Group type: EXPERIMENTAL
Intervention: Physician knowledge of patient expectations
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Physicians prescribing medications
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Physician discussion of prevention or prognosis
Number of subjects: 360

Group type: COMPARATOR
Intervention: Characteristics of care between physicians who knew and did not know patient expectations
Number of subjects: 360
Study: 3652706

Group type: EXPERIMENTAL
Intervention: Surfactant (2 ml/kg; phospholipid concentration, 100 mg/ml) administered via naso-endotracheal tube during standardized ventilatory maneuvers
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (no surfactant)
Number of subjects: 8
Study: 30972900

Group type: EXPERIMENTAL
Intervention: Intervention involving play-based incentives for sunscreen application
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 20
Study: 28865459

Group type: EXPERIMENTAL
Intervention: Indigo naturalis ointment (n = 16)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (n = 8)
Number of subjects: 24
Study: 25925404

Group type: EXPERIMENTAL
Intervention: NEMEX-TJR plus knee school educational package (KS)
Number of subjects: 45

Group type: COMPARATOR
Intervention: KS alone
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: NEMEX-TJR plus KS
Number of subjects: 45
Study: 23868287

Group type: EXPERIMENTAL
Intervention: BiOSS stent
Number of subjects: 32

Group type: COMPARATOR
Intervention: DES
Number of subjects: 32
Study: 21771253

Group type: EXPERIMENTAL
Intervention: Angular velocity at 30° s(‐1)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Angular velocity at 60° s(‐1)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Angular velocity at 120° s(‐1)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Angular velocity at 240° s(‐1)
Number of subjects: 11
Study: 19688315

Group type: EXPERIMENTAL
Intervention: Qingre Buyi Decoction (QBD) plus conventional treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional treatment (Control)
Number of subjects: 60
Study: 16776607

Group type: EXPERIMENTAL
Intervention: Web-based (WB) training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standardized Patient (SP) training
Number of subjects: 30
Study: 14742998

Group type: EXPERIMENTAL
Intervention: Oral ganciclovir (1 g every 8 hr) from days 15 to 100 after transplantation
Number of subjects: 64

Group type: COMPARATOR
Intervention: Intravenous ganciclovir (6 mg/kg once per day on Monday‐Friday of each week) from days 15 to 100 after transplantation
Number of subjects: 64
Study: 12900528

Group type: EXPERIMENTAL
Intervention: Etoricoxib 120 mg
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Naproxen sodium 550 mg
Number of subjects: 73
Study: 10882945

Group type: EXPERIMENTAL
Intervention: Retinoic acid with Avène medical water
Number of subjects: 69

Group type: COMPARATOR
Intervention: Retinoic acid alone
Number of subjects: 69
Study: 8967861

Group type: EXPERIMENTAL
Intervention: Endocrine-cell (EC) carcinomas
Number of subjects: 53
Study: 1453403

Group type: EXPERIMENTAL
Intervention: Laser vaporization
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Involved epithelium
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Noninvolved vaginal epithelium
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Koilocytosis
Number of subjects: 56